Canada issues health warning, two lots of MAR-Amlodipine recalled over possible pill mix-up
Latest news on WhatsApp أجدد الأخبار على واتسابHealth Canada has issued a public advisory and recalled two lots of MAR-Amlodipine 5 mg after reports that some bottles may contain the wrong tablets, identified as midodrine 2.5 mg.
MAR-Amlodipine is prescribed for high blood pressure and chest pain, while midodrine is used for low blood pressure. Health Canada warned that taking midodrine instead of amlodipine could lead to serious harms, including dangerously high blood pressure, dizziness, fainting, slow heartbeats and potential organ damage, with children at higher risk of severe side effects.
The affected product is MAR-Amlodipine 5 mg (DIN 02371715), lots 2472021 and 2472021A (expiry July 2027). Patients are urged to check tablets immediately: the correct tablets are white to off-white, flat and eight-sided with “210” and “5” markings, while the wrong tablets are white, round and marked “M2”. Any bottles containing round tablets should be returned to a pharmacy for replacement and the round tablets should not be taken.
Health Canada said it is monitoring Marcan Pharmaceuticals Inc.’s recall and investigation, including corrective and preventive actions, and will update the public if new risks are identified.
You May Also Like
Authors
-
Tahani Elghazaly5258 Posts
